Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Purpose. To explore the safety and efficacy of gemcitabine and docetaxel (GEMDOC) in previously treated patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods. Patients with advanced SCCHN previously pretreated with one or two lines of pallia...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kafri, Zyad, Heilbrun, Lance K., Sukari, Ammar, Yoo, George, Jacobs, John, Lin, Ho-Sheng, Mulrenan, Heather, Smith, Daryn, Kucuk, Omer
Materialtyp: Artigo
Språk:Inglês
Publicerad: International Scholarly Research Network 2012
Ämnen:
Clinical Study
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359684/
https://ncbi.nlm.nih.gov/pubmed/22655205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/159568
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk